Medscape - October 12, 2023
Belinda Ostrowsky, M.D., says wastewater monitoring of viruses and other seasonal illnesses can be helpful to local public health officials, clinicians, and hospital systems because it provides insight into viral trends at the community level. Dr. Ostrowsky is clinical associate professor of medicine at Einstein.
Dr. Ostrowsky's ProfileMore coverage on Dr. Ostrowsky
USA Today - October 1, 2023
Shivani Agarwal, M.D., M.P.H., discusses a study she led that found structural issues, such as poverty, racism, and unequal access to healthy food and high-quality medical care, contribute to the high rates of diabetes around the world. Dr. Agarwal is associate professor of medicine and associate director of the Fleischer Institute for Diabetes and Metabolism at Einstein and an endocrinologist at Montefiore.
Dr. Agarwal's ProfileMore coverage on Dr. Agarwal
Fox5 - September 28, 2023
Shelby Freedman Harris, Psy.D., says muscle relaxation, deep breathing, keeping a regular sleep schedule, and having a relaxing bedtime routine may help improve sleep quality and quantity. Dr. Harris is clinical associate professor in The Saul R. Korey Department of Neurology and of psychiatry and behavioral sciences at Einstein.
Dr. Harris' ProfileMore coverage on Dr. Harris
The Washington Post - September 26, 2023
Jonathan Alpert, M.D., Ph.D., warns against self-medicating with psychedelics for depression or other mental health disorders, noting that patients need to be evaluated and under the care of trained providers if psychedelics are used in their treatment. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
MedPageToday - September 22, 2023
Jill Crandall, M.D., a member of the FDA's Endocrinologic and Metabolic Drugs Advisory Committee, explains that she voted against approving an implant device for type 2 diabetes in part because patient data weren't consistent regarding the device's delivery of a GLP-1 agonist drug. Dr. Crandall is professor of medicine and the Jacob A. and Jeanne E. Barkey Chair in Medicine at Einstein, and chief of endocrinology at Einstein and Montefiore.
Dr. Crandall's ProfileMore coverage on Dr. Crandall
NPR - September 21, 2023
Jonathan Alpert, M.D., Ph.D., says patients using drugs like Ozempic and Wegovy, commonly prescribed for diabetes, should talk to their doctors about any mental health issues they may be experiencing while taking the medications. Dr. Alpert is the Dorothy and Marty Silverman Chair in Psychiatry at Einstein and is chair and professor of psychiatry and behavioral sciences at Einstein and Montefiore.
Dr. Alpert's ProfileMore coverage on Dr. Alpert
The Philadelphia Inquirer - August 24, 2023
Sofiya Milman, M.D., M.S., describes the SuperAgers Family Study, which seeks to discover drivers of healthy longevity in people over the age of 95. Dr. Milman is associate professor of medicine and of genetics and director of Human Longevity Studies at Einstein’s Institute for Aging Research and an endocrinologist at Montefiore.
Additional coverage includes CNBC and Fox32 Chicago
Dr. Milman's ProfileMore coverage on Dr. Milman
Leaders - August 19, 2023
Lynne Holden, M.D., discusses Einstein’s longstanding commitment to diversity and inclusion and her own background mentoring students in medicine. Dr. Holden is professor of emergency medicine and senior associate dean for diversity and inclusion at Einstein and an emergency medicine physician at Montefiore.
Dr. Holden's ProfileMore coverage on Dr. Holden
The New York Times - August 10, 2023
John Greally, M.D., Ph.D., D.Med., says he remains skeptical about the value of so-called epigenetic clocks, which estimate an organism's age by analyzing chemical tags on its DNA. Dr. Greally is director of the Center for Epigenomics, professor of genetics and of pediatrics, and chief of the division of genomics at Einstein, and a pediatric geneticist at Children’s Hospital at Montefiore.
Dr. Greally's ProfileMore coverage on Dr. Greally
The New York Times - July 27, 2023
Nir Barzilai, M.D., describes his research on genetic mutations that may slow the effects of aging. Dr. Barzilai is professor of medicine and of genetics, the Ingeborg and Ira Leon Rennert Chair in Aging Research, and director of the Institute for Aging Research at Einstein, and an endocrinologist at Montefiore.
Additional coverage includes CNN
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
MedPageToday - July 22, 2023
Karen Bonuck, Ph.D., describes the devastating impacts of long COVID and advises healthcare professionals to educate themselves on diagnosis and treatment and to advocate for legislation that will benefit patients. Dr. Bonuck is professor of family and social medicine, of obstetrics & gynecology and women's health, and of pediatrics at Einstein and co-director of the Rose F. Kennedy University Center of Excellence in Developmental Disabilities at Einstein and Montefiore.
Dr. Bonuck's ProfileMore coverage on Dr. Bonuck
BronxNetOpen - July 19, 2023
Jennifer Hardell, an Einstein medical student, explains her recent research that found air pollution is associated with longer hospital stays for children with asthma.
CBS News - July 19, 2023
Simon Rego, Psy.D., says that recharging and refreshing can be helpful for mental health, but it's important to be mindful to avoid spending too much time in bed, a viral trend known as "bed rotting." Dr. Rego is professor of psychiatry and behavioral sciences, chief of psychology, and director of psychology training at Einstein and Montefiore.
Dr. Rego's ProfileMore coverage on Dr. Rego
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is professor and chair of ophthalmology and visual sciences and the Paul Henkind Chair in Ophthalmology at Einstein and Montefiore.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder
Newsweek - February 1, 2012
Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research.
Dr.Pirofski's ProfileMore coverage on Dr.Pirofski